Sort   by:  
 Page size 
UnknownCYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk.
Not available
S-EPMC4815813 | biostudies-literature
UnknownInosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
Not available
S-EPMC3940333 | biostudies-literature
UnknownDefinitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Not available
S-EPMC11704390 | biostudies-literature
UnknownCis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
Not available
S-EPMC4580986 | biostudies-literature
UnknownCell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Not available
S-EPMC4459387 | biostudies-literature
UnknownGenome-wide association studies identify four ER negative-specific breast cancer risk loci.
Not available
S-EPMC3771695 | biostudies-literature
UnknownIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140 | biostudies-literature
UnknownBRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Not available
S-EPMC4907358 | biostudies-literature
UnknownIdentification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
Not available
S-EPMC4853421 | biostudies-literature
UnknownFine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Not available
S-EPMC3852923 | biostudies-literature
Sort   by:  
 Page size